JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.

Johnson & Johnson (NYSE:JNJ) has a sizable and broadly positioned operation, with strong representation in both the medical ...

These top medical stocks may be able to provide defensive safety after President Trump's tariff hikes and July's unfavorable ...

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.

US President Trump imposed 200% tariff on pharmaceuticals affecting US drug prices and supply chain, but analysts say it may not happen soon.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Shares of European pharmaceutical companies sold off on Friday after President Donald Trump issued letters to 17 companies, ...

Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Johnson & Johnson (NYSE: JNJ) ranks among the best forever stocks to invest in. Prior to the company’s second-quarter ...